Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation

被引:0
作者
Kohsuke Shakushiro
Hiroki Kawano
Mari Nakata
Aya Kita
Atsushi Maeda
Shunsuke Watanabe
Kazuhiro Sako
Naoto Oku
机构
[1] Astellas Pharma Inc.,Pharmaceutical Research and Technology Labs., Technology
[2] ,Drug Discovery Research,
[3] Astellas Pharma Inc.,Department of Medical Biochemistry, School of Pharmaceutical Sciences
[4] University of Shizuoka,undefined
[5] ,undefined
来源
Pharmaceutical Research | 2015年 / 32卷
关键词
Drug release; Liposome; Modeling; Simulation; Sepantronium bromide (YM155);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:238 / 247
页数:9
相关论文
共 159 条
[1]  
Nakahara T(2011)Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models Cancer Sci 102 614-21
[2]  
Kita A(2007)YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts Cancer Res 67 8014-21
[3]  
Yamanaka K(2012)Pharmacokinetics, distribution and excretion of YM155 monobromide, a novel small-molecule survivin suppressant, in male and pregnant or lactating female rats Biopharm Drug Dispos 33 160-9
[4]  
Mori M(2013)Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model Nucl Med Biol 40 221-6
[5]  
Amino N(2008)Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin J Clin Oncol 26 5198-203
[6]  
Takeuchi M(2012)A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer Ann Oncol 23 968-73
[7]  
Nakahara T(1965)Diffusion of univalent ions across the lamellae of swollen phospholipids J Mol Biol 13 238-52
[8]  
Kita A(1968)Phospholipid spherules (liposomes) as a model for biological membranes J Lipid Res 9 310-8
[9]  
Yamanaka K(2008)Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development J Pharm Sci 97 4696-740
[10]  
Mori M(2012)Pharmacokinetics and disposition of various drug loaded liposomes Curr Drug Metab 13 372-95